Li Feng received her Ph.D. from Sichuan University of China in 2005. From 2007 still the present, she worked as the Executive Deputy Director of the Regenerative Medicine Research Center of West China Hospital of Sichuan University in China. To date, Prof. Li has published more than 100 papers, including more than 70 papers in international journals, and has been cited more than 1,200 times. Prof. Li Feng, as the person in charge, presided over 2 general projects of the National Natural Science Foundation of China and other national and provincial basic innovation research more than 10 projects. Her subject areas of expertise include cell biology in liver diseases and regenerative medicine. Together with the cooperative team, Prof. Li Feng’s team successfully researched and developed the world's first stem cell 3D bio-printed blood vessel. In 2022, it was successfully approved by the National Health Commission for the first stem cell 3D bio-printed blood vessel clinical project and started clinical trials. At the same time, in the field of cell biology, she also conducts in-depth research on the regulatory mechanisms of cell homeostasis in liver diseases now.
Li Feng received her Ph.D. from Sichuan University of China in 2005. From 2007 still the present, she worked as the Executive Deputy Director of the Regenerative Medicine Research Center of West China Hospital of Sichuan University in China. To date, Prof. Li has published more than 100 papers, including more than 70 papers in international journals, and has been cited more than 1,200 times. Prof. Li Feng, as the person in charge, presided over 2 general projects of the National Natural Science Foundation of China and other national and provincial basic innovation research more than 10 projects. Her subject areas of expertise include cell biology in liver diseases and regenerative medicine. Together with the cooperative team, Prof. Li Feng’s team successfully researched and developed the world's first stem cell 3D bio-printed blood vessel. In 2022, it was successfully approved by the National Health Commission for the first stem cell 3D bio-printed blood vessel clinical project and started clinical trials. At the same time, in the field of cell biology, she also conducts in-depth research on the regulatory mechanisms of cell homeostasis in liver diseases now.